Blood Pressure-Lowering Therapy.
Sign Up to like & getrecommendations! Published in 2020 at "Handbook of experimental pharmacology"
DOI: 10.1007/164_2020_372
Abstract: Extensive evidence demonstrates that lowering blood pressure can substantially reduce the risk of atherosclerotic cardiovascular disease and death.In light of the latest 2018 European Society of Cardiology/European Society of Hypertension Joint Guidelines, we summarize the… read more here.
Keywords: lowering therapy; cardiology; blood pressure; blood ... See more keywords
White Matter Hyperintensities and Blood Pressure Lowering in Acute Intracerebral Hemorrhage: A Secondary Analysis of the ATACH-2 Trial
Sign Up to like & getrecommendations! Published in 2019 at "Neurocritical Care"
DOI: 10.1007/s12028-019-00761-0
Abstract: Background It is not clear whether subsets of patients with intracerebral hemorrhage (ICH) benefit from intensive blood pressure (BP) lowering. We evaluated whether white matter hyperintensities (WMH) burden influences response to this therapy. Methods Retrospective… read more here.
Keywords: wmh; intracerebral hemorrhage; analysis; blood pressure ... See more keywords
Plasma kallikrein cleaves and inactivates apelin-17: Palmitoyl- and PEG-extended apelin-17 analogs as metabolically stable blood pressure-lowering agents.
Sign Up to like & getrecommendations! Published in 2019 at "European journal of medicinal chemistry"
DOI: 10.1016/j.ejmech.2019.01.040
Abstract: Apelins are human peptide hormones with various physiological activities, including the moderation of cardiovascular, renal, metabolic and neurological function. Their potency is dependent on and limited by proteolytic degradation in the circulatory system. Here we… read more here.
Keywords: apelin analogs; pressure lowering; blood pressure; plasma kallikrein ... See more keywords
USE OF DRUGS WITH BLOOD PRESSURE (BP) LOWERING PROPERTIES AND OUTCOMES IN PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION (HFPEF) AND LOW SYSTOLIC BP (SBP)
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(18)31461-x
Abstract: Discharge SBP read more here.
Keywords: drugs blood; outcomes patients; use drugs; blood pressure ... See more keywords
705 CHARACTERISING OLDER ADULTS’ RISK OF HARM FROM BLOOD-PRESSURE LOWERING MEDICATIONS: A SUB-ANALYSIS FROM THE PRIME STUDY
Sign Up to like & getrecommendations! Published in 2022 at "Age and Ageing"
DOI: 10.1093/ageing/afac035.705
Abstract: Hypertension is a major risk factor for cardiovascular disease and death. Randomised trials in older adults with relatively few co-morbidities recommend treatment of their hypertension [1]. However, blood-pressure lowering medications increase the risk of medication-related… read more here.
Keywords: pressure lowering; mrh; blood pressure; lowering medications ... See more keywords
Effect of mineralocorticoid antagonists on blood pressure lowering: overview and meta-analysis of randomized controlled trials in hypertension
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Hypertension"
DOI: 10.1097/hjh.0000000000001671
Abstract: Objectives: Although mineralocorticoid antagonists (MRAs) have been proposed as effective fourth-line blood pressure (BP)-lowering agents in resistant hypertension, this effect in hypertension at-large is unclear. We evaluated whether MRAs-mediated BP lowering is both effective and… read more here.
Keywords: mineralocorticoid antagonists; blood pressure; resistant hypertension; hypertension effect ... See more keywords
Blood pressure-lowering drugs and secondary prevention of cardiovascular disease: systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Hypertension"
DOI: 10.1097/hjh.0000000000001720
Abstract: Objective: To systematically evaluate the efficacy of five commonly used blood pressure-lowering drugs in reducing cardiovascular events among patients with nonacute cardiovascular disease, but without heart failure. Methods: We searched PubMed, EMBASE, and Cochrane Central… read more here.
Keywords: blood pressure; disease; lowering drugs; pressure lowering ... See more keywords
The Blood Pressure Lowering Treatment Trialists’ Collaboration: methodological clarifications of recent reports
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Hypertension"
DOI: 10.1097/hjh.0000000000003107
Abstract: Epidemiological evidence has consistently shown that people with higher systolic or diastolic blood pressure are at greater risk of cardiovascular diseases. However, there has been limited randomized evidence to determine the role of blood pressure… read more here.
Keywords: blood; pressure lowering; lowering treatment; blood pressure ... See more keywords
Intensive blood pressure lowering in chronic kidney disease: the time has come
Sign Up to like & getrecommendations! Published in 2017 at "Current Opinion in Nephrology and Hypertension"
DOI: 10.1097/mnh.0000000000000316
Abstract: Purpose of review Release of the findings from the Systolic Blood Pressure Intervention Trial has resulted in a renewed examination of intensive blood pressure (BP) lowering. Only a few national hypertension guidelines (Canada and Australia)… read more here.
Keywords: chronic kidney; intensive blood; blood pressure; blood ... See more keywords
Age‐related macular degeneration and mortality in SARS‐CoV‐2‐infected patients
Sign Up to like & getrecommendations! Published in 2020 at "Acta Ophthalmologica"
DOI: 10.1111/aos.14685
Abstract: 3.2 0.9, and 1.0 1.3 after 12 months of follow-up, that is an average reduction of more than 2 pressure-lowering eye drops after one year. Sixty-seven per cent of eyes did not need pressure-lowering eye… read more here.
Keywords: age related; lowering eye; eye drops; pressure lowering ... See more keywords
Intensive blood pressure lowering provides no additional benefits and results in more adverse events
Sign Up to like & getrecommendations! Published in 2017 at "Evidence-Based Medicine"
DOI: 10.1136/ebmed-2016-110594
Abstract: Commentary on : Qureshi AI, Palesch YY, Barsan WG, et al. Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage. N Engl J Med 2016;375:1033-43. Elevated blood pressure (BP) in acute intracerebral haemorrhage (ICH) is common and… read more here.
Keywords: trial; intensive blood; blood pressure; blood ... See more keywords